BR9913596A - Preparação de liberação prolongada de droga com longa duração - Google Patents

Preparação de liberação prolongada de droga com longa duração

Info

Publication number
BR9913596A
BR9913596A BR9913596-5A BR9913596A BR9913596A BR 9913596 A BR9913596 A BR 9913596A BR 9913596 A BR9913596 A BR 9913596A BR 9913596 A BR9913596 A BR 9913596A
Authority
BR
Brazil
Prior art keywords
release preparation
long
drug release
term drug
fat
Prior art date
Application number
BR9913596-5A
Other languages
English (en)
Other versions
BR9913596B1 (pt
Inventor
Akihiko Sano
Hiroo Maeda
Masako Kajihara
Syunsuke Tani
Toshihiko Sugie
Original Assignee
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharma filed Critical Sumitomo Pharma
Publication of BR9913596A publication Critical patent/BR9913596A/pt
Publication of BR9913596B1 publication Critical patent/BR9913596B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Patente de Invenção: <B>"PREPARAçãO DE LIBERAçãO PROLONGADA DE DROGA COM LONGA DURAçãO" <D>. A presente invenção refere-se a uma preparação de liberação prolongada de uma droga lipofílica compreendendo uma dispersão de droga onde a droga lipofílica e uma substância solúvel em água são dispersas, em um estado sólido na temperatura do corpo de um animal ou um ser humano ao qual a preparação deve ser administrada, em um material impermeável à água e biocompatível.
BRPI9913596-5A 1998-09-10 1999-09-06 Composição farmacêutica de liberação prolongada de droga com longa duração. BR9913596B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25617098 1998-09-10
JP256170/1998 1998-09-10
PCT/JP1999/004809 WO2000015199A1 (fr) 1998-09-10 1999-09-06 Preparation de liberation prolongee de medicament a effet durable

Publications (2)

Publication Number Publication Date
BR9913596A true BR9913596A (pt) 2001-05-22
BR9913596B1 BR9913596B1 (pt) 2014-12-23

Family

ID=17288890

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9913596-5A BR9913596B1 (pt) 1998-09-10 1999-09-06 Composição farmacêutica de liberação prolongada de droga com longa duração.

Country Status (18)

Country Link
US (1) US6756048B1 (pt)
EP (1) EP1112739B1 (pt)
JP (1) JP4753471B2 (pt)
KR (1) KR100602823B1 (pt)
CN (1) CN1198599C (pt)
AT (1) ATE502626T1 (pt)
AU (1) AU754996B2 (pt)
BR (1) BR9913596B1 (pt)
CA (1) CA2342587C (pt)
DE (1) DE69943299D1 (pt)
DK (1) DK1112739T3 (pt)
ES (1) ES2360180T3 (pt)
MX (1) MXPA01002609A (pt)
NZ (1) NZ510400A (pt)
PT (1) PT1112739E (pt)
TW (1) TWI246928B (pt)
WO (1) WO2000015199A1 (pt)
ZA (1) ZA200101853B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
US7363091B1 (en) * 2001-07-11 2008-04-22 Pacesetter Inc. Method of molding silicone elastomer drug carrier in an endocardial lead
NZ528240A (en) * 2003-09-23 2006-03-31 Graham Francois Duirs And Lind Treatment and control device
GB2410748A (en) * 2004-02-03 2005-08-10 Johnson & Johnson Medical Ltd Medicated polyurethane foams
WO2006099514A2 (en) * 2005-03-14 2006-09-21 Biotegra, Inc. Drug delivery compositions and related methods
WO2009029958A2 (en) * 2007-08-30 2009-03-05 Sunstorm Research Corporation Implantable delivery device
CN103124565A (zh) 2010-08-06 2013-05-29 大日本住友制药株式会社 用于控制水溶性药物释放的药物制剂
CN103140226B (zh) 2010-08-06 2015-07-08 大日本住友制药株式会社 用于治疗脊髓损伤的制剂
CN102908316B (zh) * 2012-11-12 2014-07-30 西南大学 伊维菌素水溶性固体分散体及其制备方法
EP4512394A3 (en) 2015-06-03 2025-10-22 Triastek, Inc. Dosage forms and use thereof
CN104983695B (zh) * 2015-07-17 2018-01-09 江西博莱大药厂有限公司 一种盐酸头孢噻呋脂质体冻干剂及其制备方法
JP6878417B2 (ja) * 2016-02-17 2021-05-26 トリアステック インコーポレイテッド 剤形およびそれらの使用
KR102637575B1 (ko) * 2016-10-05 2024-02-20 타이탄 파머슈티컬즈 인코퍼레이티드 버스트 방출이 감소된 약물 전달용 이식 가능한 장치
CA3051614A1 (en) 2017-01-26 2018-08-02 Triastek, Inc. Dosage forms of controlled release at specific gastrointestinal sites
US11571391B2 (en) 2018-01-09 2023-02-07 Triastek, Inc. Oral drug dosage forms compromising a fixed-dose of an ADHD non-stimulant and an ADHD stimulant
CN112353765B (zh) * 2020-11-09 2022-05-31 山东华辰制药有限公司 一种头孢噻呋微球的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3279996A (en) 1962-08-28 1966-10-18 Jr David M Long Polysiloxane carrier for controlled release of drugs and other agents
DE2445971A1 (de) * 1974-09-24 1976-04-08 Schering Ag Arzneimittelwirkstofftraeger ii
US4191741A (en) 1978-09-22 1980-03-04 Eli Lilly And Company Removable drug implant
DE2902414A1 (de) * 1979-01-23 1980-08-07 Hoechst Ag Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung
JPS5793909A (en) * 1980-12-03 1982-06-11 Sankyo Co Ltd Carcinostatic pharmaceutical having directivity to specific internal organ and its preparation
JPS5944310A (ja) * 1982-09-06 1984-03-12 Nippon Kayaku Co Ltd シリコ−ンゴム系徐放性製剤
JPH0761959B2 (ja) * 1985-10-11 1995-07-05 住友製薬株式会社 シリコンエラストマ−系徐放性製剤
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
DE3684446D1 (de) * 1985-12-28 1992-04-23 Sumitomo Pharma Arzneimittel mit verzoegerter stossweiser freisetzung.
JPH04224513A (ja) * 1990-12-26 1992-08-13 Olympus Optical Co Ltd 徐放剤用担体およびその製造方法
US5153002A (en) * 1991-03-04 1992-10-06 University Of Montreal Biocompatible gradient controlled release implant
JPH0778017A (ja) * 1993-06-30 1995-03-20 Kobe Steel Ltd 動作物体間の干渉チェック方法及びその装置
US5490962A (en) * 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
JPH07330581A (ja) * 1994-06-08 1995-12-19 Mitsui Toatsu Chem Inc 埋込型徐放性免疫抑制剤

Also Published As

Publication number Publication date
MXPA01002609A (es) 2002-04-08
EP1112739A1 (en) 2001-07-04
KR20010072691A (ko) 2001-07-31
CN1316900A (zh) 2001-10-10
WO2000015199A1 (fr) 2000-03-23
EP1112739A4 (en) 2009-05-27
BR9913596B1 (pt) 2014-12-23
AU754996B2 (en) 2002-11-28
NZ510400A (en) 2003-03-28
KR100602823B1 (ko) 2006-07-19
ZA200101853B (en) 2001-11-14
US6756048B1 (en) 2004-06-29
ES2360180T3 (es) 2011-06-01
ATE502626T1 (de) 2011-04-15
CN1198599C (zh) 2005-04-27
EP1112739B1 (en) 2011-03-23
DE69943299D1 (de) 2011-05-05
CA2342587A1 (en) 2000-03-23
PT1112739E (pt) 2011-03-31
JP4753471B2 (ja) 2011-08-24
TWI246928B (en) 2006-01-11
AU5449399A (en) 2000-04-03
DK1112739T3 (da) 2011-04-26
CA2342587C (en) 2008-11-18

Similar Documents

Publication Publication Date Title
DK1112739T3 (da) Langtidsafgivende depot-præparat
AU7888398A (en) Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
DE3579068D1 (de) Arzneimittelenthaltende matrizen fuer einfuehrungen in zonen mit cellularen lesionen.
DE69819481D1 (de) Formulierungen von clarithromycin mit verlängerter wirkstoff-freisetzung
CA2416383A1 (en) Solution-, dispersion- or emulsion-producing film dermatics
DE50005099D1 (de) Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften
PT1119557E (pt) Derivados de indeno- nafto- e benzociclohepta-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorecticos
DE68909772D1 (de) Diclofenac-Natrium-Arzneizubereitung mit verlängerter Wirkstoffabgabe.
DE69433818D1 (de) Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
ATE220547T1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
PT1181047E (pt) Composicao compreendendo esfingomielinase alcalina para utilizacao como preparacao distetica suplemento alimentar ou produto farmaceutico
PT1041985E (pt) Combinacao de compostos benzociclo-heptapiridina e farmacos antineoplasicos para tratar doencas proliferativas
WO2003018064A3 (en) Lipophilic drug compositions
AU3401093A (en) Therapeutic agent for threatened abortion
ATE243419T1 (de) Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften
EP0236002A3 (en) Pharmaceutical composition comprising a medicament and a water-swellable polymer
ES2018737A6 (es) Composicion plaguicida mejorada y procedimiento para su preparacion.
ES2185310T3 (es) Agente antivirico herbario.
ITRM990339A0 (it) Derivati di principi attivi ad attivita&#39; terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali deriva
BR9608271A (pt) Dispositivo para misturar uma composição farmaceutica preferivelmente seca e granulada com um agente preferivelmente fluido para formar uma preparação preferivelmente um gel ou similar e processos para preparar uma preparação farmacêutica e para administrar a mesma a um ser vivo
DE59107240D1 (de) Emulgatorfreie Emulsionspolymere in pharmazeutischen Zubereitungen mit verzögerter Wirkstofffreigabe und ihre Herstellung
NO20022739L (no) Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)-2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on og nevroleptika for behandling eller forhindring av psykotiske lidelser
WO1999066902A8 (en) Injectable pharmaceutical formulations of partricin derivatives
FR2572932B1 (fr) Medicament insoluble administre localement dans l&#39;oreille
FR2786699B1 (fr) Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: DAINIPPON PHARMACEUTICAL CO., LTD (JP)

Free format text: TRANSFERIDO DE: SUMITOMO PHARMACEUTICALS COMPANY, LIMITED

B25D Requested change of name of applicant approved

Owner name: DAINIPPON SUMITOMO PHARMA CO., LTD. (JP)

Free format text: ALTERADO DE: DAINIPPON PHARMACEUTICAL CO., LTD.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 25O DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/12/2014, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time
B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2478 DE 03-07-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.